Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.
A double-blind trial was performed in 60 women to establish the effectiveness of an ergot alkaloid, 2-Br-alpha-ergocryptine (ergocryptine; CB 154), in suppressing puerperal lactation and to compare it with stilboestrol and a placebo. At the doses selected ergocryptine and stilboestrol were equally effective.
D001940:Breast / Q000187:drug effects; D002986:Clinical Trials as Topic; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000494:pharmacology; D004304:Dosage Forms; D004876:Ergot Alkaloids / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D010919:Placebos; D049590:Postpartum Period; D011247:Pregnancy
D004304:Dosage Forms; D004876:Ergot Alkaloids; D010919:Placebos; D004054:Diethylstilbestrol